Results 181 to 190 of about 23,750 (257)

HPV 18 L1-VLP [PDF]

, 2020
openaire   +1 more source

Comparison of Vaccine Platforms for Machupo Virus. [PDF]

Vaccines (Basel)
Erickson R, Muramatsu H, Tiwari S, Sriram S, Coirada FC, Pardi N, Bates P.   +6 more
europepmc   +1 more source

Characterization of high affinity IgM and IgG monoclonal antibodies against norovirus variants GII.4 and GII.17. [PDF]

Protein Sci
Tagawa J, Yanaka S, Kato Y, Masuda A, Lee JM, Senoo A, Oyama K, Uchihashi T, Nishida M, Kusakabe T, Caaveiro JMM.   +10 more
europepmc   +1 more source

Plant-based production of virus-like particles from hepatitis C virus. [PDF]

Planta
López-Castillo LM, Gonzalez-Castro R, Sánchez-Segura L, Aguilar-Barragán BA, Lim MAG.   +4 more
europepmc   +1 more source

Oral immunization with filovirus-like particles partially protects IFNAR^-/^- mice against lethal ebola virus challenge. [PDF]

Sci Rep
Escudero-Pérez B, Lasala F, Luczkowiak J, Labiod N, Rivas G, Morgado H, Casasnovas JM, Nave J, Wurr S, García-Bernalt Diego J, Muñoz-Fontela C, Delgado R.   +11 more
europepmc   +1 more source

Virus-like and Virus Replicon Particles Targeting Multiple B-Cell Antigens Do Not Protect Against African Swine Fever Virus. [PDF]

Vaccines (Basel)
Lotonin K, García-Nicolás O, Kilb N, Krämer S, Chang X, Engeroff P, Mehinagic K, Donzé N, Brito F, Liniger M, Lieknina I, Cernova D, Balta I, González-García G, Rueda P, Zimmer G, Benarafa C, Ruggli N, Roth G, Tars K, Bachmann M, Summerfield A.   +21 more
europepmc   +1 more source

Fecal virome transplantation attenuates arthritis in mice by remodeling gut ecology, systemic tryptophan metabolism, and innate immune responses. [PDF]

NPJ Biofilms Microbiomes
He L, Yuan D, Li Q, Zhang X, Niu K, Li X, Ou Y, Du H, Yuan J, Duan Y, Niu H.   +10 more
europepmc   +1 more source

Development of a scalable production bioprocess for HIV-1 virus-like particles coupling continuous VLP harvesting with end-to-end downstream processing. [PDF]

Sci Rep
Lorenzo E, Lavado-García J, Pérez-Rubio P, Cattaneo M, Gòdia F, Cervera L.   +5 more
europepmc   +1 more source

Immunogenicity and protective efficacy of MERS CoV, NL140422, and HKU4 spike protein nanoparticle vaccines. [PDF]

Npj Viruses
Halfmann PJ, Lee JS, Wang T, Duffy A, Kawaoka Y, Kane RS.   +5 more
europepmc   +1 more source

Inhibitory Effect of <i>Curcuma xanthorrhiza</i> Extract Against SARS-CoV-2 D614G Virus-Like Particle (VLP): Implications for COVID-19 Therapy Development. [PDF]

ScientificWorldJournal
Mushlih M, Bemova M, Marzouk HA, Kusuma KH, Rohmah IN, Fitriana N, Prima A, Christina YI, Dwijayanti DR, Mustikaningtyas D, Widodo N, Djati MS, Widyarti S, Rifa'i M.   +13 more
europepmc   +1 more source